Topic: Health
Researchers from the Universities of Edinburgh and Bristol used zebrafish to study spinal damage. They found that a drug already used to treat osteoporosis can block mineral buildup in the spine, which causes back pain.
Back pain is a common problem for many people around the world. In fact, it's estimated that over 9 million people in the UK alone live with back pain.
A major cause of back pain is the deterioration of the discs that cushion the bones of the spine. This condition is called intervertebral disc degeneration (IVDD). IVDD can be caused by inherited factors and can lead to spinal fusion and mineral buildup, making the tissue between the bones abnormally hard.
To study this problem, researchers used zebrafish as a model organism. Zebrafish are small fish that are often used in scientific research because they develop quickly and can be easily bred without certain genes. The researchers created zebrafish that were missing a gene associated with collagen IX, a protein that helps bind together the structural fibers inside spinal discs.
As the zebrafish grew older, they developed spinal abnormalities that closely resembled disc disease in people. Their vertebrae fused, and mineral deposits caused the tissue between the bones to become abnormally hard. The researchers then examined patterns of gene activity in the fish to determine which genes had become more or less active.
Their analysis revealed problems with fat processing and with mTOR, a pathway that regulates growth. They also found changes involving phosphate control and vitamin A signaling. Each of these processes has been associated with abnormal mineral accumulation.
The researchers then tested several approaches to reduce the spinal damage. One approach was to use a bisphosphonate, a type of bone-protecting medication already used to treat osteoporosis. This drug prevented minerals from accumulating in the spine and reduced spinal fusion.
Another approach was to feed the zebrafish less food or to give them drugs that suppressed fat metabolism. These approaches also reduced spinal damage.
The study suggests that phosphate regulation and fat metabolism may be promising areas for the development of future medicines to treat back pain.
Why It Matters
This breakthrough could lead to new treatments for back pain, which affects millions of people around the world. It's especially exciting because it uses a drug already approved for use in humans, which means that clinical trials can begin sooner.
Key Facts
- 9 million people in the UK live with back pain
- Intervertebral disc degeneration (IVDD) is a major cause of back pain
- Zebrafish were used as a model organism to study spinal damage
- A bisphosphonate, a drug already used for osteoporosis, reduced mineral buildup in the spine
- Phosphate regulation and fat metabolism may be promising areas for future treatments
Key Terms
- Bisphosphonate
- A type of bone-protecting medication that prevents minerals from accumulating in the bones
- mTOR
- A pathway that regulates growth and is involved in abnormal mineral accumulation
Implications
This breakthrough could lead to new treatments for back pain, which affects millions of people around the world. It's especially exciting because it uses a drug already approved for use in humans, which means that clinical trials can begin sooner.
Leave a comment